Liptruzet Approved By FDA, Fails To Lower Heart Disease Risk

Some cardiologists questioned the regulatory approval of a combination drug that lowers "bad cholesterol" but fails to reduce the overall risk of heart disease.

http://www.medicaldaily.com/articles/15168/20130504/new-cholesterol-drug-liptruzet-fails-lower-heart.htm